Davita Inc vs Zillow Group Inc Class C — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Zillow Group Inc Class C trades at $29.24 (market cap $6.17B). The key difference: Davita Inc is the larger of the two by market cap, and Davita Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Zillow Group Inc Class C for 39 Days on average.
| DVA | Z | |
|---|---|---|
Market Cap | $11.28B | $6.17B |
Volume | 650,294 | 2,822,928 |
Sector | Health | Media |
52-Week High | $240.96 | $78.04 |
52-Week Low | $103.87 | $27.13 |
Typical Hold Time | 113 Days | 39 Days |
Enterprise Value | $24.00B | $6.04B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Zillow Group (Z) trades at $27.28, down 1.52% amid bearish technical signals and a challenging housing market. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability with net income of $23M. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed. Analyst consensus remains mixed with a $60.33 price target representing significant upside potential from current levels.
The stock presents a compelling risk-reward opportunity with strong analyst price targets but faces headwinds from rising mortgage rates and housing market volatility. Zillow's strategic pivot to an integrated transaction platform and AI integration positions it for long-term growth, though near-term performance depends on housing market stabilization and execution of their business transformation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →